These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19738211)

  • 1. The OMERACT Initiative. Towards a reference approach to derive QALY for economic evaluations in rheumatology.
    Boonen A; Maetzel A; Drummond M; Suarez-Almazor M; Harrison M; Welch V; Tugwell PS
    J Rheumatol; 2009 Sep; 36(9):2045-9. PubMed ID: 19738211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valuing health for clinical and economic decisions: directions relevant for rheumatologists.
    Harrison MJ; Bansback NJ; Marra CA; Drummond M; Tugwell PS; Boonen A
    J Rheumatol; 2011 Aug; 38(8):1770-5. PubMed ID: 21807800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case.
    Maetzel A; Tugwell P; Boers M; Guillemin F; Coyle D; Drummond M; Wong JB; Gabriel SE;
    J Rheumatol; 2003 Apr; 30(4):891-6. PubMed ID: 12672224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.
    Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks P; Day R; Strand V; Wells G
    J Rheumatol; 1999 Jan; 26(1):207-9. PubMed ID: 9918265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations and preliminary proposals for defining a reference case for economic evaluations in ankylosing spondylitis.
    Bansback N; Maetzel A; Drummond M; Anis A; Marra C; Conway P; Boers M; Tugwell P; Boonen A
    J Rheumatol; 2007 May; 34(5):1178-83. PubMed ID: 17477483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
    Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
    J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues of consensus and debate for economic evaluation in rheumatology.
    Coyle D; Welch V; Shea B; Gabriel S; Drummond M; Tugwell P
    J Rheumatol; 2001 Mar; 28(3):642-7. PubMed ID: 11296975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients?
    Trenaman L; Boonen A; Guillemin F; Hiligsmann M; Hoens A; Marra C; Taylor W; Barton J; Tugwell P; Wells G; Bansback N
    J Rheumatol; 2017 Dec; 44(12):1899-1903. PubMed ID: 28298567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritis.
    Gabriel S; Drummond M; Maetzel A; Boers M; Coyle D; Welch V; Tugwell P;
    J Rheumatol; 2003 Apr; 30(4):886-90. PubMed ID: 12672223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of care in rheumatic diseases: performance measures and improvement.
    Harrington JT
    Curr Opin Rheumatol; 2008 Mar; 20(2):153-8. PubMed ID: 18349744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The OMERACT-ICF Reference Group: integrating the ICF into the OMERACT process: opportunities and challenges.
    Boonen A; Stucki G; Maksymowych W; Rat AC; Escorpizo R; Boers M;
    J Rheumatol; 2009 Sep; 36(9):2057-60. PubMed ID: 19738213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.
    Wolfe F; Lassere M; van der Heijde D; Stucki G; Suarez-Almazor M; Pincus T; Eberhardt K; Kvien TK; Symmons D; Silman A; van Riel P; Tugwell P; Boers M
    J Rheumatol; 1999 Feb; 26(2):484-9. PubMed ID: 9972992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of health economic decisions in actual practice: the role of behavioral economics. Summary of the presentation given by Professor Daniel Kahneman at the ISPOR 10th Annual International Meeting First Plenary Session, May 16, 2005, Washington, DC, USA.
    Value Health; 2006; 9(2):65-7. PubMed ID: 16626409
    [No Abstract]   [Full Text] [Related]  

  • 14. QALYs and the capability approach.
    Cookson R
    Health Econ; 2005 Aug; 14(8):817-29. PubMed ID: 15693028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In pursuit of QALY weights for relatives: empirical estimates in relatives caring for older people.
    Davidson T; Krevers B; Levin LA
    Eur J Health Econ; 2008 Aug; 9(3):285-92. PubMed ID: 17849155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equity in health care prioritisation: an empirical inquiry into social value.
    Stolk EA; Pickee SJ; Ament AH; Busschbach JJ
    Health Policy; 2005 Nov; 74(3):343-55. PubMed ID: 16226144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient perspective on outcomes in rheumatology -- a position paper for OMERACT 9.
    Kirwan JR; Newman S; Tugwell PS; Wells GA
    J Rheumatol; 2009 Sep; 36(9):2067-70. PubMed ID: 19738215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology.
    Gabriel SE; Tugwell P; Drummond M
    Ann Rheum Dis; 2002 Apr; 61(4):370-3. PubMed ID: 11874847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm.
    O'Neill J; Rader T; Guillemin F; Boonen A; Christensen R; Lyddiatt A; Pardo JP; Welch V; Singh JA; Tugwell P
    J Rheumatol; 2014 Jan; 41(1):150-2. PubMed ID: 24128775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring outcomes in palliative care: limitations of QALYs and the road to PalYs.
    Normand C
    J Pain Symptom Manage; 2009 Jul; 38(1):27-31. PubMed ID: 19615624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.